| 000 | 01142 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516201819.0 | ||
| 264 | 0 | _c20141121 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1520-5711 | ||
| 024 | 7 |
_a10.1080/10543406.2013.863779 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAsakawa, Takashi | |
| 245 | 0 | 0 |
_aBayesian model averaging continual reassessment method for bivariate binary efficacy and toxicity outcomes in phase I oncology trials. _h[electronic resource] |
| 260 |
_bJournal of biopharmaceutical statistics _c2014 |
||
| 300 |
_a310-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBayes Theorem |
| 650 | 0 | 4 |
_aClinical Trials, Phase I as Topic _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHirakawa, Akihiro | |
| 700 | 1 | _aHamada, Chikuma | |
| 773 | 0 |
_tJournal of biopharmaceutical statistics _gvol. 24 _gno. 2 _gp. 310-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10543406.2013.863779 _zAvailable from publisher's website |
| 999 |
_c23619461 _d23619461 |
||